Key result
Hyperoside preconditioning limits infarct size and improves cardiac function in rat ischemia-reperfusion via PI3K/Akt activation.
Why the study?
The protective effect of hyperoside preconditioning against myocardial ischemia-reperfusion injury and its relationship with the PI3K/Akt signaling pathway in rats was investigated.
Hyperoside remains experimental in ischemia-reperfusion models; leaves open translation to human cardioprotection pending clinical trials.
To investigate the protective effect of preconditioning with hyperoside ( Hyp) against myocardial ischemia-reperfusion injury (MIRI) in rats and the role of PI3K/Akt signaling pathway. MIRI was established by ligation of left anterior descending coronary artery for 30 min followed by reperfusion for 120 min in rats. Male SD rats were randomly divided into five groups: sham group,model group (MIRI),Hyp preconditioning group(Hyp), Hyp preconditioning + LY294002 (a PI3K/Akt signaling pathway inhibitor) group (Hyp + LY), and LY294002 group (LY). At the end of reperfusion, hemodynamic parameters were recorded as left ventricular systolic pressure (LVSP) , left ventricular end-diastolic pressure ( LVEDP) and maximal rate of increase and decrease of left ventricular pressure (± dP/dt(max)). Myocardial infaret size, the oxidative stress markers, myocardial enzymes indicators and inflammatory factors were also analyzed. The expressions of Akt, p-Akt, Bax and Bcl-2 proteins was detected by using Western blot method. The results showed that Hyp preconditioning remarkably improved cardiac constriction and relaxation function, reduced myocardial infarct size and enhanced the activities of oxidative stress markers about correlated to MIRI, such as superoxide dismutase (SOD), catalase (CAT) and glutathione-peroxidase (GSH-Px) and decreased the contents of malondialdehyde (MDA) as compared with MIRI group. Simultaneouly, the levels of myocardial enzymes, i. e. creatine kinase ( CK) and creatine kinase MB isoenzyme (CK-MB), and inflammatory factors, for instance tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) were decreased. Hyp pretreatment apparently restrained myocardial apoptosis as evidenced by decreasing the level of Bax expression, increasing the levels of phosphorylation of Akt and Bcl-2 expression. These effects were inhibited by LY294002, a blocker of PI3K/Akt signaling pathway. These findings indicated that the cardioprotection of Hyp preconditioning against MIRI may be related to activating PI3K/Akt signaling pathway, upregulating the expression of BCL-2 protein and down-regulating the expression of Bax protein.
No takes yet. Share an insight, caveat, or question.
Han et al. (2015) studied Myocardial ischemia-reperfusion injury (MIRI). Hyperoside preconditioning vs. Model group (MIRI) was evaluated on Cardiac constriction/relaxation function and myocardial infarct size. Hyperoside preconditioning remarkably improved cardiac function and reduced myocardial infarct size in rats with myocardial ischemia-reperfusion injury by activating the PI3K/Akt signaling pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: